Translations:Hyperlipidemia/11/ja: Difference between revisions

Latest revision as of 21:05, 13 April 2024

Information about message (contribute)

This message has no documentation. If you know where or how this message is used, you can help other translators by adding documentation to this message.

Message definition (Hyperlipidemia)

==== Type I ====
{{anchor|type I}}
Type I hyperlipoproteinemia exists in several forms:
* [[Lipoprotein lipase deficiency|Lipoprotein lipase deficiency (type Ia)]], due to a deficiency of [[lipoprotein lipase]] (LPL) or altered [[apolipoprotein C2]], resulting in elevated [[chylomicron]]s, the particles that transfer fatty acids from the [[digestive tract]] to the [[liver]]
* Familial apoprotein CII deficiency (type Ib), a condition caused by a lack of lipoprotein lipase activator.
* Chylomicronemia due to circulating inhibitor of lipoprotein lipase (type Ic)

I型

I型高リポ蛋白血症にはいくつかの病型がある：

リポ蛋白リパーゼ欠乏症（Ia型）、リポ蛋白リパーゼ（LPL）の欠乏またはアポリポ蛋白C2の変化により、脂肪酸を消化管から肝臓に移行させる粒子であるカイロミクロンが上昇する。
家族性アポ蛋白CII欠乏症（Ib型）は、リポ蛋白リパーゼ活性化因子の欠乏によって起こる。
循環リポ蛋白リパーゼ阻害剤によるカイロミクロン血症（Ic型）

Translations:Hyperlipidemia/11/ja: Difference between revisions

Latest revision as of 21:05, 13 April 2024

I型

Navigation menu

Search